Boryung Pharma wins patent lawsuit

The landscape of the nation’s pharmaceutical market is expected to change as Boryung Pharmaceutical has won a patent suit against Novartis, the world’s biggest player in the sector.

Boryung was successful in its legal battle against Novartis, citing a decision by the Korea Intellectual Property Tribunal (KIPO) on March 29 to nullify Novartis’s Gleevec (imatinib mesylate) patent after filing ...